Delivery Order SPE2DB22D3301-SPE2DB25FY4FT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed price contract valued at $1,125.60. This non-set-aside competitive award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $1,839.98. This non-set-aside delivery order, issued on August 29, 2025, with completion targeted for September 2, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $19,087.50. This non-competitive delivery order, valued through September 30, 2025, represents a continuation of pharmaceutical support services through AmerisourceBergen's existing federal contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $2,641.58. The award, issued on August 20, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city. This...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,766.03 for Modafinil 100 mg tablets (30-count packages) with a firm fixed price structure and an ultimate completion date of September 16, 2025. This non-set-aside contract was competitively awarded and reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal medical procurement systems. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed-price contract valued at $8,071.20, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,690.40 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for the supply of Modafinil 100 mg tablets in 30-count units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,476.93 with a firm fixed price structure and an ultimate completion date of July 30, 2025. The delivery order was issued on July 29, 2025, with performance taking place at the vendor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $13,026.80. This competitively awarded, firm fixed-price contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (quantity 30s) under a firm fixed price contract. The contract, valued at $2,749.28, was competitively awarded without set-aside designation and carries an ultimate completion date of August 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY4FTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $3,748.11, with an ultimate completion date of May 5, 2025. This non-competitive delivery order represents a continuation of the pharmaceutical supply services that AmerisourceBergen provides to the federal government. The contract is issued under the company's parent Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle that enables broad pharmaceutical supply capability across military healthcare systems globally through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare operations. This delivery order exemplifies the company's role as a prime pharmaceutical supplier under the DLA Troop Support Medical IDC, which covers a comprehensive range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor program strategy anticipates multiple regional awards among several contractors to optimize global medical supply chain efficiency for defense and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 5/2/25 |